(Q44701797)

5 December 2017

A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer (English)

1 reference

positron emission tomography

5 December 2017

1 reference

1 reference

5

R Edward Coleman

1 reference

5 December 2017

Gonzalo V Gonzalez-Stawinski

1

1 reference

5 December 2017

Anthony Lemaire

2

1 reference

5 December 2017

Faisal Merchant

3

1 reference

5 December 2017

Elizabeth O'Halloran

4

1 reference

5 December 2017

David H Harpole

6

1 reference

5 December 2017

Thomas A D'Amico

7

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

The Journal of Thoracic and Cardiovascular Surgery

5 December 2017

1 reference

5 December 2017

126

1 reference

5 December 2017

1900-1905

1 reference

5 December 2017

6

1 reference

5 December 2017

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Revisions in the International System for Staging Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Positron emission tomography in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Prospective investigation of positron emission tomography in lung nodules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Preoperative staging of non-small-cell lung cancer with positron-emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

The current role of mediastinoscopy in the evaluation of thoracic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Regional lymph node classification for lung cancer staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

Factors associated with false-positive staging of lung cancer by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2803%2901036-5

10.1016/S0022-5223(03)01036-5

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference